Vivek Subbiah, MD
Vivek Subbiah, MD is currently an Assistant Professor in the Department of Investigational Cancer Therapeutics (A Phase 1 Program), Division of Cancer Medicine, at The University of MD Anderson Cancer Center.He completed a combined residency in Internal Medicine and Pediatrics at Case Western Reserve University, MetroHealth, Cleveland Ohio. Dr. Subbiah has a unique training background as he is one of the few physicians in the nation/world to have training in oncology in both adults and children. He is board certified in both Internal Medicine and Pediatrics and has completed fellowships in both adult and pediatric oncology at the MD Anderson Cancer Center.
Dr. Subbiah has been working closely with colleagues in Cancer Medicine and Pediatrics to develop novel treatment methods including molecularly targeted therapies, radiopharmaceutical studies and immunotherapeutic strategies to improve the outcomes of AYA with cancer. In addition, by using cutting-edge molecular profiling and the large portfolio of targeted drugs, he is positioning to lead the way in identifying new treatments for the atypical cancers that these young people develop His research interests include adolescent and young adult oncology, phase 1 trials – drug development ( molecularly targeted therapy, radiopharmaceutical studies and immunotherapeutic studies), and clinical trials with molecularly targeted agents in targetable rare diseases (eg,sarcomas,NF2). He also has a passion for N-of- ONE studies in cancer patients that have dramatic responses to therapies by in depth analysis through next generation sequencing, morphoproteomics, and other cutting edge methods for analysis of response/ resistance mechanisms.